Excellos

Excellos Provides Customized cGMP Services for the Development and Production of Cell Therapies. Excellos Utilizes Proprietary Cell Characterization Technology to Reduce Variability in Clinical Responses and Increase the Probability of Success. Current Applications Support TIL-Based Therapies, Autologous and Allogeneic CAR-T/NK Therapies, and TCR Therapies. Their Tailored Services Include Donor Recruitment, Cell Isolation, Transduction, Expansion, and Scaling Up of GMP Manufacturing.